Debt (Tables)

6 Months Ended

Jun. 30, 2017

Debt [Abstract]

Summary Of Notes Payable

		As of June 30, 2017
(Dollars in thousands)		Maturity Date	Contractual Facility		Balance, Gross		Balance, Net(3)		Stated Interest Rate	Effective Interest Rate (1)
Denominated in USD
	Trust Preferred Securities (USA)	April 30, 2027	$	27,913	$	27,913	$	27,447	5.17%	5.20%
	Bank of America Credit Facility (USA)	November 28, 2019		55,000		36,500		36,424	3.73%	3.65%
	Bank of America Line of Credit (USA)	October 31, 2019		5,000		--		-	4.21%	4.21%
	Cinema 1, 2, 3 Term Loan (USA)(4)	September 1, 2019		19,702		19,702		19,232	3.25%	3.25%
	Minetta & Orpheum Theatres Loan (USA)(4)	June 1, 2018		7,500		7,500		7,434	3.81%	3.81%
	U.S. Corporate Office Term Loan (USA)(4)	January 1, 2027		9,825		9,825		9,698	4.64%	4.64%
	Union Square Construction Financing (USA)(4)	December 29, 2019		57,500		8,000		5,146	5.46%	5.46%
Denominated in foreign currency ("FC") (2)
	NAB Corporate Term Loan (AU)	June 28, 2019		51,045		25,331		25,215	2.62%	2.62%
	Westpac Corporate Credit Facility (NZ)	December 31, 2018		38,807		--		--	3.70%	3.70%
			$	272,292		134,771		130,596

(1)Effective interest rate includes the impact of interest rate derivatives hedging the interest rate risk associated with Trust Preferred Securities and Bank of America Credit Facility that were outstanding as of June 30, 2017.

(2)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of June 30, 2017.

(3)Net of deferred financing costs amounting to $4.2 million.

(4)The loan for our Minetta & Orpheum Theatres was obtained from Santander Bank. The term loan for our Cinema 1,2,3 Theatre was refinanced during the third quarter of 2016 with Valley National Bank. The term loan, which is collateralized by our new U.S Corporate Headquarters office building, was obtained with Citizens Asset Finance, Inc.  In December 2016, we successfully negotiated the construction financing for our Union Square redevelopment project, $8.0 million of which was advanced from the total construction loan limit of $57.5 million. 

		As of December 31, 2016
(Dollars in thousands)		Maturity Date	Contractual Facility		Balance, Gross		Balance, Net(3)		Stated Interest Rate	Effective Interest Rate (1)
Denominated in USD
	Trust Preferred Securities (USA)	April 30, 2027	$	27,913	$	27,913	$	27,340	4.89%	5.20%
	Bank of America Credit Facility (USA)	November 28, 2019		55,000		39,950		39,759	3.27%	3.90%
	Bank of America Line of Credit (USA)	October 31, 2019		5,000		--		--	3.77%	3.77%
	Cinema 1, 2, 3 Term Loan (USA)(4)	September 1, 2019		19,901		19,901		19,356	3.25%	3.25%
	Minetta & Orpheum Theatres Loan (USA)(4)	June 1, 2018		7,500		7,500		7,398	3.38%	3.38%
	U.S. Corporate Office Term Loan (USA)(4)	January 1, 2027		8,363		8,363		8,239	4.64%	4.64%
	Union Square Construction Financing (USA)(4)	December 29, 2019		57,500		8,000		4,751	4.52%	4.52%
Denominated in FC (2)
	NAB Corporate Term Loan (AU)	June 30, 2019		48,080		28,558		28,421	2.64%	2.64%
	Westpac Corporate Credit Facility (NZ)	March 31, 2018		36,877		8,350		8,350	3.80%	3.80%
			$	266,134	$	148,535	$	143,614

(1)Effective interest rate includes the impact of interest rate derivatives hedging the interest rate risk associated with Trust Preferred Securities and Bank of America Credit Facility that were outstanding as of December 31, 2016.

(2)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2016.

(3)Net of deferred financing costs amounting to $4.9 million.

(4) The loan for our Minetta & Orpheum Theatres was obtained from Santander Bank. The term loan for our Cinema 1,2,3 Theatre was refinanced during the third quarter of 2016 with Valley National Bank. The term loan, which is collateralized by our new U.S Corporate Headquarters office building, was obtained with Citizens Asset Finance, Inc.. In December 2016, we successfully negotiated the construction financing for our Union Square redevelopment project, $8.0 million of which was advanced from the total construction loan limit of $57.5 million. 

Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs

	Dollars in thousands
Balance Sheet Caption	June 30, 2017		December 31, 2016
Debt - current portion	$	8,058	$	567
Debt - long-term portion		95,091		115,707
Subordinated debt		27,447		27,340
Total borrowings	$	130,596	$	143,614

Schedule Of Construction Financing

(Dollars in thousands)			Facility Limits and Advances
Financing Component		Lender		Facility Limit			Advanced-to- Date		Remaining Facility		Interest Rate(1)	Maturity Date(2)
Mezzanine loan	Tammany Mezz Investor LLC			$	7,500	$		--	$	7,500	Greater of (i) 10.50% and (ii) Adjusted LIBOR + 10%	December 29, 2019
Senior loan	Bank of the Ozarks				8,000			8,000		--	Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%	December 29, 2019
Building loan	Bank of the Ozarks				31,130			--		31,130	Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%	December 29, 2019
Project loan	Bank of the Ozarks				10,870			--		10,870	Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%	December 29, 2019
Total Union Square Financing				$	57,500	$		8,000	$	49,500

(1)Not to exceed the New York State maximum lawful borrowing rate, which typically is 16%.

(2)Allowable for up to two (2) extension request options, one (1) year for each extension request.